Next Article in Journal
Determination of the structure of a new nanoscaled ultrasound contrast agent
Previous Article in Journal
Numerical Simulation of Drop Impact on Wetted and Dry Surfaces
 
 
Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2016). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Conference Report

Magnetoliposomes: Liposomal Contrast Agents

1
Institute of Biophysics and Nanosystems Research, Austrian Academy of Sciences, Graz, 8042, Austria
2
Institute of Medical Engineering, University of Technology, Graz, 8010, Austria
3
Medical University, Graz, 8010, Austria
*
Author to whom correspondence should be addressed.
Sci. Pharm. 2010, 78(3), 569; https://doi.org/10.3797/scipharm.cespt.8.LNM01
Submission received: 12 July 2010 / Accepted: 12 July 2010 / Published: 12 July 2010

Abstract

Magnetoliposomes (MLs) are phospholipid vesicles encapsulating magnetic nanoparticles utilised as contrast agents for targeted molecular Magnetic Resonance Imaging (MRI). [...]

Share and Cite

MDPI and ACS Style

FRASCIONE, D.; SABA-LEPEK, M.; DIWOKY, C.; OPRIESSNIG, P.; STOLLBERGER, R.; ALMER, G.; MANGGE, H.; PRASSL, R. Magnetoliposomes: Liposomal Contrast Agents. Sci. Pharm. 2010, 78, 569. https://doi.org/10.3797/scipharm.cespt.8.LNM01

AMA Style

FRASCIONE D, SABA-LEPEK M, DIWOKY C, OPRIESSNIG P, STOLLBERGER R, ALMER G, MANGGE H, PRASSL R. Magnetoliposomes: Liposomal Contrast Agents. Scientia Pharmaceutica. 2010; 78(3):569. https://doi.org/10.3797/scipharm.cespt.8.LNM01

Chicago/Turabian Style

FRASCIONE, D., M. SABA-LEPEK, C. DIWOKY, P. OPRIESSNIG, R. STOLLBERGER, G. ALMER, H. MANGGE, and R. PRASSL. 2010. "Magnetoliposomes: Liposomal Contrast Agents" Scientia Pharmaceutica 78, no. 3: 569. https://doi.org/10.3797/scipharm.cespt.8.LNM01

Article Metrics

Back to TopTop